Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
0.241
-0.039 (-13.96%)
At close: Apr 28, 2026, 4:00 PM EDT
0.240
-0.001 (-0.41%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Jaguar Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 11.51 | 11.69 | 9.76 | 11.96 | 4.34 | Upgrade
|
| Revenue Growth (YoY) | -1.52% | 19.75% | -18.36% | 175.80% | -53.81% | Upgrade
|
| Cost of Revenue | 3.77 | 1.96 | 2.04 | 2.02 | 2.33 | Upgrade
|
| Gross Profit | 7.74 | 9.73 | 7.72 | 9.94 | 2 | Upgrade
|
| Selling, General & Admin | 27.88 | 24.02 | 23.05 | 26.71 | 26 | Upgrade
|
| Research & Development | 24.97 | 16.54 | 18.6 | 17.65 | 15.08 | Upgrade
|
| Operating Expenses | 52.85 | 40.57 | 41.64 | 44.35 | 41.08 | Upgrade
|
| Operating Income | -45.11 | -30.83 | -33.92 | -34.42 | -39.07 | Upgrade
|
| Interest Expense | -0.07 | -0.23 | -6.38 | -12.72 | -8.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.22 | -9.43 | -4.93 | 0.93 | -2.72 | Upgrade
|
| EBT Excluding Unusual Items | -51.4 | -40.5 | -45.23 | -46.21 | -50.21 | Upgrade
|
| Asset Writedown | - | - | -0.37 | - | - | Upgrade
|
| Other Unusual Items | -1.8 | 1.25 | 3.7 | -2.19 | -2.39 | Upgrade
|
| Pretax Income | -54 | -39.25 | -41.9 | -48.4 | -52.6 | Upgrade
|
| Earnings From Continuing Operations | -54 | -39.25 | -41.9 | -48.4 | -52.6 | Upgrade
|
| Minority Interest in Earnings | 0.56 | 0.76 | 0.6 | 0.94 | 0.01 | Upgrade
|
| Net Income | -53.43 | -38.49 | -41.3 | -47.45 | -52.6 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.14 | - | - | - | - | Upgrade
|
| Net Income to Common | -53.58 | -38.49 | -41.3 | -47.45 | -52.6 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 0 | 0 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 0 | 0 | - | - | Upgrade
|
| Shares Change (YoY) | 691.89% | 1809.95% | - | - | - | Upgrade
|
| EPS (Basic) | -22.97 | -130.69 | -2678.17 | - | - | Upgrade
|
| EPS (Diluted) | -22.97 | -130.69 | -2678.17 | - | - | Upgrade
|
| Free Cash Flow | -23.73 | -29.4 | -33.24 | -33.18 | -34.98 | Upgrade
|
| Free Cash Flow Per Share | -10.17 | -99.82 | -2155.63 | - | - | Upgrade
|
| Gross Margin | 67.21% | 83.28% | 79.13% | 83.11% | 46.18% | Upgrade
|
| Operating Margin | -391.87% | -263.76% | -347.50% | -287.85% | -901.36% | Upgrade
|
| Profit Margin | -465.42% | -329.30% | -423.11% | -396.91% | -1213.26% | Upgrade
|
| Free Cash Flow Margin | -206.12% | -251.52% | -340.56% | -277.53% | -806.83% | Upgrade
|
| EBITDA | -43.2 | -28.93 | -31.91 | -32.43 | -37.36 | Upgrade
|
| EBITDA Margin | - | -247.51% | - | -271.28% | - | Upgrade
|
| D&A For EBITDA | 1.91 | 1.9 | 2.01 | 1.98 | 1.72 | Upgrade
|
| EBIT | -45.11 | -30.83 | -33.92 | -34.42 | -39.07 | Upgrade
|
| EBIT Margin | - | -263.76% | - | -287.85% | - | Upgrade
|
| Revenue as Reported | 11.51 | 11.69 | 9.76 | - | 4.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.